abstract |
The present invention relates to a method for preventing myocardial tissue stress in a patient, more specifically for Doxorubicin or Adriamycin induced myocardial tissue injury/ischemia/stress/hypoxia by reducing the levels of Creatine Kinase-MB which comprises administering to the patient an effective amount of 5-Methoxytryptamine or a salt thereof. |